Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Procaps Group, S.A. (PROCF : OTC)

• Company Description    Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia. Number of Employees: 4,500

• Price / Volume Information    Yesterday's Closing Price: $0.03 Daily Weekly Monthly 20 Day Moving Average: 318 shares Shares Outstanding: 2,303.86 (millions) Market Capitalization: $57.60 (millions) Beta: 56.96 52 Week High: $1.45 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.42% -5.27% 12 Week 3.33% -4.52% Year To Date -0.42% -98.90%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9 RUE DE BITBOURG - LUXEMBOURG,N4 L-1273 LUX ph: 356 7995-6138 fax: - ir@sofgenpharma.com http://www.sofgenpharma.com

• General Corporate Information    Officers Ruben Minski - Chief Executive Officer Alejandro E. Weinstein - Chairman Camilo Camacho - Chief Operations Officer Daniel Bernal - Chief Financial Officer Mauricio Castaneda Caballero - Vice-President Peer Information Procaps Group, S.A. (GSAC) Procaps Group, S.A. (CASIF) Procaps Group, S.A. (ALCD.) Procaps Group, S.A. (OMNN) Procaps Group, S.A. (CGPI.) Procaps Group, S.A. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: L7756P102 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 2,303.86 Most Recent Split Date: (:1) Beta: 56.96 Market Capitalization: $57.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©